免费视频色 I 久久网中文字幕 I 日本三级欧美三级 I 日本丰满bwbwbw I 国产蜜臀在线 I 成人免费黄色大片 I 久草手机在线视频 I 日本丰满护士bbw I av色欲无码人妻中文字幕 I 69国产精品 I 强奷乱码中文字幕熟女导航 I 天天色免费视频 I 91无遮挡 I 亚洲视频在线视频观看视频在线 I 天堂中文字幕在线观看 I 精品亚洲va在线va天堂资源站 I 中文 欧美 日韩 I 都市激情av I 呦呦精品 I 极品少妇被后入内射视 I 杨幂毛片午夜性生毛片 I 亚洲情一区 I 欧美精品v国产精品v日韩精品 I 国产成人精品aa毛片 I 91视频观看免费 I 日韩欧美中文在线视频 I 夜色毛片永久免费 I 成年人黄色免费观看 I 网友自拍视频一区 I wwwav国产 I 开心黄色网 I 日韩激情av在线 I 男生插女生的视频 I 在线观看精品国产视频 I 色先锋在线看片

Recently, NHU has secured approval for domestic drug registration of its API Coenzyme Q10, positioning the company as the first enterprise to receive such approval since the issuance of the National Medical Products Administration (NMPA)'s Announcement on Matters Related to Further Improving the Review, Approval, and Supervision of Drugs in 2019. This significant milestone indicates that our Coenzyme Q10 is at the forefront of the industry and paves the way for a new API market, presenting fresh opportunities for our development.

About Coenzyme Q10

Coenzyme Q10, a fat-soluble antioxidant, plays a crucial role in fortifying the myocardium, preventing heart aging, preventing and combating cancer, maintaining cardiovascular health, and enhancing overall vitality. The significant market demand for Coenzyme Q10 exists both domestically and internationally. The production of API Coenzyme Q10 necessitates stringent quality control and safety inspections, leading to rigorous requirements for production processes and product quality. NHU stands out as the inaugural company to receive such approval and recognition, demonstrating the company’s capability to produce high-quality API Coenzyme Q10 since the drug approval reform by the NMPA in 2019.

In its role as a guardian of nutrition and health, NHU is committed to the journey of open innovation. Starting from addressing future and potential market needs, we collaborate with academia and industry to delve into the cutting edges of chemical and biological science and technology and foster innovation and advancement, leading to the successful development of products like the Vitamin Series, Moxifloxacin Hydrochloride, and Taurine. NHU aims to create value for the entire industry and society, establishing a "Safety Moat" for human health.